Skip to main content
Drug bottle and Pill

Compare Zepbound vs. Wegovy

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Tirzepatide (Zepbound) and semaglutide (Wegovy) are both medications used to help with weight loss and belong to the class of glucagon-like peptide-1 (GLP-1) receptor agonists. However, they have some differences. Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, while semaglutide is solely a GLP-1 receptor agonist. Tirzepatide is also approved to treat moderate-to-severe sleep apnea, whereas semaglutide is approved to lower the risk of heart attack, stroke, and death due to heart problems in adults with heart disease. Both medications are injected under the skin once a week, but their dosing schedules differ. Tirzepatide starts at 2.5 mg and can go up to 15 mg, while semaglutide starts at 0.25 mg and can go up to 2.4 mg. Common side effects for both include nausea, diarrhea, and stomach pain. Both medications have potential interactions with other medications, such as diabetes medications, warfarin (Jantoven, Coumadin), and birth controll pills. Both are not recommended for people with a history of certain thyroid cancers.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.